Introduction
The scope and limitations of conventional methods for the estimation of paracetamol in plasma have been documented.l-2 Recently, an enzymic assay for paracetamol has been reported-based upon its hydrolysis by a microbial aryl acylamidase.s The product of the reaction, p-aminophenol, is reacted with an ammoniacal copper-cresol reagent to form an indophenol dye. 6 In the expectation that the enzymic assay would offer an unusual combination of practical advantages 6-speed, simplicity, and sensitivity-a collaborative trial was planned. The objects of this trial were to establish the linearity and precision of the assay, both within and between laboratories, its accuracy relative to chromatographic methods of analysis, and its general reliability and ruggedness in the context of the diagnosis and treatment of paracetamol poisoning. The trial was conducted in four phases, with the following main objectives: Phase 1 To confirm that the enzymic assay gave acceptable results on patients' specimens relative to precise comparison procedures based on different analytical principles. Phase 2 To confirm the precision and accuracy of a selected comparison procedure by duplicate analyses of quality control and patients' specimens in two different laboratories. Phase 3 To establish the transferability of the enzymic assay to laboratories that had not been *Present address: Regional Laboratory for Toxicology, Dudley Road Hospital, Birmingham BI8 7QH.
involved in its development, and to make further estimates of its precision relative to the selected comparison procedure. Phase 4 To optimise the enzyme assay in the light of experience gained during the preceding phases.
Analytical methods
Plasma paracetamol was determined by gas-liquid chromatography (GC) according to Huggett et aU and by high performance liquid chromatography (HPLC) according to Horvitz and Jatlow. 8 The following enzymic assay was used in the first two phases of the trial: REAGENTS AND CALIBRATION SOLUTIONS These were prepared using reagent grade chemicals as follows:
Buffered enzyme Aryl acylamidase from the Centre for Applied Microbiology and Research, Porton, was supplied in 100 mmol/l Tris HCl, pH 8·6, containing SO % (vIv) glycerol and stored at -20 aC.
This preparation had an activity of 70-80 units per ml, 1 unit being defined as the amount of enzyme that hydrolysed 1 flomol p-nitroacetanilide per min at 30 aC. The enzyme was diluted 1 in 10 with 100 rnmol/l Tris HCI, pH 8·6, before use, and the solution was stored at 4aC.
Colour reagent Ten volumes of 1 % (vIv) aqueous
o-cresol were mixed with 14 volumes of deionised water and 3 volumes of ammoniacal copper sulphate (0·5% (wIv) copper sulphate (anhydrous) in aqueous ammonia, 0·27 molfl). 353
PHASE 2
The GC procedure was adopted as the comparison method of choice, to be set up in two laboratories. Fig. 1 Results obtained with the enzymic method as used in the phase] study compared with: (a) an HPLC method (laboratory C, n = 60), regression parameters y = L-Llx -0·03, r = 0·993; and (b) a GC method (laboratory A, n = 60,) regression parameters (omitting the three discrepant values) y = 0·91 x+0·02, r = 0-991. that gave discrepant results, there was also very good correlation between the HPLC estimates which had originally been made on the freshly taken specimens and the subsequent GC estimates on the same specimens after freezing and thawing.
Interferences from other drugs Of the 60 patients' specimens in the second series, 12 were shown to contain one or more additional drugs-amitriptyline, carbamazepine, dextropropoxyphene, ethanol, nitrazepam, nortriptyline, pentobarbitone, phenothiazines, or salicylate. There was no evidence that any of these drugs interfered with either the enzymic, GC or HPLC assays. 
Calibration solutions A stock calibration was prepared at a concentration of 100 mmol/l by dissolving paracetamol in deionised water. Five working calibration solutions covering the range 0·5-2·5 mmol/l were prepared by dilution with deionised water.
Experimental procedures and results

PROCEDURE
To 100 ILl of plasma (or calibration solution) was added 100 ILl of buffered enzyme and the preparation was incubated at room temperature for 5 min. A 2·5 ml volume of colour reagent was added, the solution was mixed, and the absorbance read after 3 min at 615 om against a colour reagent blank.
(Except as indicated below, the plasma blank values were negligible.)
Relative accuracy of the enzymic, GC and HPLC assays On analysis of the first series of 60 specimens there was good correlation between the enzymic and HPLC procedures ( Fig. la) . No outlying values were found and there was no clear indication of a constant or concentration-related bias, at least up to 3·0 010101/1 (450 mg/l). The second series of 60 specimens, analysed by the enzymic and GC procedures, gave similar results ( Fig. Ib) , However, discrepant values were obtained for three specimens with very high paracetamol concentrations (>3·0 mmol/l, 450 mg/l), Investigation of these discrepancies showed that there was no evidence of interference from an unusual metabolite of paracetamol or from other drugs (see below). However, one specimen gave a blank value corresponding to approximately 0·26 rnmol/l (40 mg/l) paracetarnol, which was much higher than values obtained with normal plasma specimens that had not been frozen. Except for the three specimens PHASE 1 Experiments in this phase were designed to (i) investigate the stability of frozen specimens from poisoned patients; (ii) establish whether the enzymic method gave acceptable results in comparison with the GC and HPLC procedures; and (iii) determine the ruggedness of the enzymic assay in respect of other drugs which might have been taken by the poisoned patients.
Measurements were made on two series of frozen plasma specimens from patients who had allegedly taken overdoses of paracetamoI. At one laboratory (C), 60 specimens were analysed by the enzymic and HPLC procedures. At another laboratory (A), 60 specimens (from 10 patients), previously analysed by HPLC, were re-analysed by GC. Figure 3a and b offers a comparison of the precision of the enzymic assays in terms of the within-batch differences (I st result minus 2nd result) between duplicate assays of the patients' specimens.
Concentration Irrmot/I) Fig. 3 Comparison of precision between the GC method and the enzymic method as used in the phase 2 study for 30 patients' samples analysed in duplicate within batch: (a) by the GC method; (b) by the enzymic method. For each patient's sample, the difference was expressed as (1st result minus 2nd result).
PHASE 3
The primary object of this phase was to assess the transferability and day-to-day performance of the enzymic method in different laboratories. Based on some observations made in phases 1 and 2, the number of reagents used was reduced. In addition, to facilitate the use of automatic dilution systems, the enzyme :reagent volume was increased to 20 times that of the sample volume (I ml and 50 !JoI, respectively). The enzyme used in this phase was provided as a Iyophilised preparation, which was reconstituted with Tris HCI buffer (100 mmol/I, pH 8.6) to give an activity of 1·0 unit per ml.
GC assay (mmol/I) Fig. 2 Results obtained with the enzymic method as used in the phase 2 study compared with the GC method: (a) in laboratory A for ten patients' samples (0) and four QC pools (e),parameters ofthe regression line y = 0·86x +0·006, r = 0·986; and (b) in laboratory B for 30 patients' samples, parameters of the regression line y = 0·88x+0·13,r = 0·991.
One laboratory (A) prepared four quality contro pools, using bovine plasma, to give nominal paracetamol concentrations of 0·33, 1·32,3·30, and 5·28 mmol/l (50, 200, 500, and 800 rng/l, respectively). These pools, together with a series of 10 patients' specimens, were analysed in duplicate by both the GC and enzymic methods. The findings of this study are summarised in Figure 2a .
The second laboratory (B) conducted a more detailed comparison of the accuracy and precision of the two methods using 30 patients' specimens. These were analysed in duplicate, in 10 batches for the GC assay and in 10 batches for the enzymic assay. Figure 2b shows the correlation between the GC and enzymic determinations for this laboratory.
Modified enzymic assay To 50 [LI of sample was added 1·0 ml of buffered enzyme, and the preparation was mixed and incubated at 30 DC for 5 min. A 1·9 ml volume of aqueous cresol (0·53 %wIv) and 100 [LI of ammoniacal copper sulphate (0·2 % (wlv) copper sulphate (anhydrous) in 0·28 mol/l ammonium hydroxide) were added. The solution was mixed and incubated at 30 DC for 3 min, after which the absorbance at 615 nm was measured against a colour reagent blank.
The modified procedure was set up in three laboratories. Duplicate analyses were carried out on the same 60 patients' specimens, using 15 batches of four samples each. Controls from two different pools were also analysed in duplicate, in each of the 15 batches. Calibration solutions were prepared independently, as above, in each laboratory.
In preliminary experiments, three observations were made: (i) colour development was slower than in the original enzymic assay procedure; (ii) some aliquots of the quality control pools supplied to one laboratory contained clots which had to be removed before analysis; (ii) the enzyme was found to be somewhat unstable when diluted to 1 unit per mi. The Iyophilised enzyme was therefore reconstituted to 10 units per mI and diluted ten-fold immediately before use.
Some patients' specimens which had been stored frozen for long periods were highly pigmented. Sample blanks were therefore set up using Tris HCl buffer in the absence of enzyme.
Precision of the enzymic assay within and between laboratories Two quality control pools were used to obtain data on reproducibility within and between 15 successive batches for two laboratories, and 10 successive batches for the third laboratory. The results (Table) show that good within-batch precision for duplicate assays was consistently achieved by laboratory A. Therefore, the enzymic assay was at least as precise as the GC and HPLC methods. The within-batch precision of the other two laboratories was not as good as that of laboratory A. Possible reasons for this variation were considered in the design of the phase 4 study.
Precision of the enzymic assay in the analysis oj patients' specimens Two of the laboratories performed duplicate assays on 59 of the 60 specimens, in 15 batches. The third laboratory performed duplicate assays on 40 of the specimens, in 10 batches. Precision profiles for the three laboratories (Fig. 4 ) reflect the performance that was achieved in the analysis of the quality control pools.
Data on these relationships are summarised in Figure 5 . The values obtained by laboratories A and Brown et al.
Summary of quality control results for two bovine serum pools spiked with paracetamol, each analysed in duplicate by the enzymic assay in successive batches in three laboratories, A, B, and C
Laboratory
Difference between duplicates (mmolll)
Low concentration poot" High concentration pool"
1·36 estimate of (0-013) (0·034) (0·052) (0·031) (0·058) (0·099) concentration (mmol/l) and (SD) ·Nominal paracetamol concentrations 0·33 mmol/l and 1· 32 mmol/l, respectively C showed good correlation (Fig. 5a ). There was a small positive bias over the concentration range corresponding to the results obtained with the two quality control pools by laboratory C (Table) . The correlation between the results obtained by laboratories A and B was less satisfactory (Fig. 5b ).
PHASE 4
In the light of the results of the preceding phases, experiments were carried out to: a define the minimum time required for maximum colour development; b define the optimum conditions for colour development; c determine colour stability; d determine enzyme stability; e determine the origin of the pigmentation of certain patients' specimens;
f determine the stability of paracetamol and its major metabolite in plasma; g establish that the enzymic assay was specific for the parent drug.
Rate of colour development Comparison of the rates of colour development in the original and modified procedures showed that there was a distinct difference .. Maximum colour was'achieved in 3 minutes in the original procedure arid in 8 minutes in the Optimum colour-reaction conditions A study was undertaken to determine the optimum concentration of each reactant with respect to colour development. In addition, the feasibility of developing a solid colour reagent was investigated; thus solid ammonium chloride was used to provide ammonium ions, and solid sodium carbonate was included to modified procedure. The pH of the reaction mixtures were 10·2 and 9·4, respectively, but the rate of colour development showed a distinct pH optimum, with rapid, maximal colour development at pH 10·2. Furthermore, the Tris concentration was also found to be critical to the rate of colour development, the maximum rate being observed at a final Tris concentration of 10 mmol/I. give a final pH of 10·2. Further progress with this formulation, however, was prevented by the deliquescence of o-cresol. Consequently, combination of the original aqueous colour reagents was examined, with a view to formulating a single colour reagent, but this proved unsatisfactory as a precipitate formed within one hour of constitution.
Further work showed that two colour reagents were necessary, the first a solution of a-cresol and the second containing copper sulphate, ammonium chloride, sodium carbonate, and Tris HCl. The copper, which was essential for rapid colour reaction, was kept in solution by the presence of Tris.
The following procedure, with a reaction volume of 3·05 ml, is now recommended for routine use. Procedure Add 50 !J.l of either serum or plasma to 1·0 ml of enzyme solution and incubate at room temperature for 3 min. Add 1·0 ml of colour reagent A and 1· 0 ml of colour reagent B. Mix, and leave at room temperature for 3 minutes before measuring the absorbance at 615 nm.
With these conditions, maximum colour development is realised in less than 2 minutes. A slightly slower rate of colour development is observed if the reagents are stored in, and used immediately from, the refrigerator. Although 'normal' serum contributes a very small absorbance (equivalent to less than 80 !J.mol/l paracetamol) at 615 nm, problems can arise with turbid or pigmented samples; therefore the use of a blank containing all the reagents except enzyme is recommended in these cases.
Stability of colour
The colour produced at pH 10·2, under optimum conditions, was found to be stable for at least one hour at room temperature.
Stability of enzyme The lyophilised enzyme was somewhat unstable when diluted to an activity of 1·0 unit per ml in buffer. However, when prepared at ten times this activity, it was stable at 4°C for at least five days. The enzyme exhibits comparable stability when made up at 1·0 unit per ml in 50 mmol/l Tris HCl buffer, pH 8·6, containing 0·1 % bovine serum albumin and 0·1 % sodium azide.
Origin of sample pigmentation p-Aminophenol undergoes oxidation in neutral or alkaline aqueous solution and may, with time, polymerise to give a brown coloured complex. To ascertain the origin of pigmentation which was observed in some specimens after frozen storage, a sample of p-aminophenol that had been allowed to polymerise was co-chrornatographed with two patients' pigmented specimens. Samples were extracted with ethyl acetate, applied as discrete spots to silica coated F ••• thin-layer chromatography plates (Merck) and chromatographed in butanol :acetic acid :water (3: 1:1). The patients' specimens contained components with Rf values identical with those of the polymerised p-aminophenol and the same brown colour. However, there was no apparent correlation between the degree of pigmentation of the specimens and their estimated Brown et al.
paracetamol concentrations. Moreover 'polymerised' p-aminophenol itself was found not to be reactive in the enzyme-based assay.
Stability of paracetamol and its metabolites The apparent presence of p-aminophenol in some plasma specimens raised the possibility of the autohydrolysis of paracetamol or its metabolites upon prolonged storage. Therefore paracetamol and its four major conjugates-glucuronide, sulphate, mercapturate, and cysteine-were each dissolved at 1·0 rnmol/l in separate aliquots of pooled human serum. Aliquots of each preparation were stored at -20°C, 4°C, and room temperature, both in daylight and in darkness. Aliquots were removed for analysis at regular intervals over a period of three months. Evidence of deterioration was found in the following cases: a Paracetamol itself had deteriorated in all samples stored at room temperature, with an approximate half-life of two months; b Paracetamol glucuronide had deteriorated in samples stored at room temperature in the daylight (approximately 50% of the conjugate had broken down to liberate free paracetamol after two months); c Paracetamol sulphate had deteriorated in samples stored at room temperature in the dark (approximately 50% of the conjugate had broken down to liberate free paracetamol after two months).
Specificity of the enzymic assay for paracetamol
Aqueous-solutions of paracetamol and of the four major conjugates were freshly prepared, each at 5 mmol/l. Three serum pools were obtained and demonstrated to be free of paracetamol by HPLC. The parent drug and each of the conjugates were diluted in each serum pool to give final concentrations of 0·5 mrnol/l and 1·0 mmol/l, Each of the solutions was assayed for paracetamol using the enzymic and HPLC techniques.
In the case of the conjugates, each solution gave absorbance values in the enzymic assay which were indistinguishable from the corresponding serum blanks «0·03 absorbance units, compared with approximately 0·25 absorbance units for the parent drug at 1.0 mmol/l). Free paracetamol could not be detected in any of the conjugate preparations using HPLC.
Discussion
This collaborative trial has afforded a clear demonstration of the scope and limitations of the enzymic assay for paracetamol. The principal findings can be reviewed in terms of the specificity, sensitivity, linearity, precision, accuracy, convenience, and ruggedness of the assay.
The microbial aryl acylamidase used in this study has a high degree of specificity for paracetamol, reacting only with the non-peptide carbon-nitrogen bonds of linear amides. The chemical reaction of the p-aminophenol so formed, with cresol, to produce an indophenol dye is also highly specific. Therefore, by coupling the enzymic hydrolysis of paracetamol with this chemical reaction, the assay achieves a very high degree of specificity for the parent drug.
No drugs commonly found in proprietary paracetamol preparations interfere with the enzymic assay or give a false colour reaction. Furthermore, no interferences have been observed with several common, but unrelated drugs, which are sometimes taken in multiple overdosage. Moreover, the four major conjugates of paracetamol are unreactive under the mild conditions of the enzymatic assay. This is an important consideration, since conjugated paracetamol may be present in the peripheral blood of poisoned patients,"
In terms of sensitivity, linearity, precision, and accuracy, the results of the trial showed that the enzymic assay was closely comparable to established HPLC and GC methods of analysis over the range 0-2·5 rnmol/l. Thus the range of plasma paracetamol concentrations usually found in poisoned patients can be covered without sample dilution.
Discrepancies between the enzymic and GC methods occurred in only three instances; in each case the specimens (which had been frozen) contained exceptionally high concentrations of paracetamol. Minor discrepancies were associated with highly pigmented specimens which had been stored frozen. Frozen storage, however, was adopted only to allow the collection of specimens over a considerable period of time, so as to provide sufficient material for the trial. In practice, patient's samples are not stored for prolonged periods before analysis and so pigmentation is unlikely to occur.
The further study that was undertaken on the elements of the colour reaction yields an explanation for the variation in analytical precision between the laboratories. Clearly, the modified assay procedure adopted in phase 3 recommended reading the absorbance before the reaction had reached completion; thus extra variability and consequent imprecision would be expected. However, there is no reasonable doubt that the findings of the trial bear out the expectation that the enzymic assay offers advantages over conventional methods in terms of speed and simplicity for comparable specificity and sensitivity. Moreover, we believe that it is suitable for use in simply equipped clinical chemistry laboratories, both as a routine and as an emergency technique.
